DelveInsight’s report, “Gene Therapy Ophthalmology Insight - Pipeline Assessment, Market Trend, Technology and Competitive Landscape, 2017” emphasizes on the currently under development Gene Therapy products in Opthalmology.
The report covers 15+ companies, which are active in this field with 42 products and various technologies. This report includes: Gene Therapy products in Ophthalmology by companies and Research Activities by Institutes in this area. The report provides in-depth analysis of the product profiles covering their pre-clinical and clinical studies, collaboration details and deal values, technologies and targeted indications. The report further gives information on market drivers and barriers followed by the SWOT Analysis.
- Overview of the Gene Therapy products in Ophthalmology
- Pipeline scenario of Gene Therapy products in Ophthalmology under development different companies and research institutes
- Competitive landscape of products
- Pipeline analysis across different phases, emerging trends and comparative analysis of pipeline products with detailed clinical profiles including: mechanism of action, route of administration and molecule type along with product development activities
- Coverage of licensors, collaborators and development partners, deal terms and deal values
- Highlights of latest developmental technologies for Gene Therapy products in Ophthalmology
- Market drivers and barriers along with the SWOT analysis
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Delve Insight’s team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, news websites, government websites, trade journals, white papers, magazines, trade associations, books, industry portals, industry associations and access to available databases.